Ifp Advisors, Inc Cyto Dyn Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.27 - $2.46 $6,507 - $12,605	-5,124 Reduced 55.25%	4,150 $9,000
Q2 2021 Jul 13, 2021	BUY	$1.67 - $3.98 $2,852 - $6,797	1,708 Added 22.57%	9,274 $17,000
Q1 2021 Apr 30, 2021	BUY	$2.12 - $7.15 $3,309 - $11,161	1,561 Added 26.0%	7,566 $21,000
Q4 2020 Jan 25, 2021	BUY	$2.02 - $6.0 $3,690 - $10,962	1,827 Added 43.73%	6,005 $32,000
Q3 2020 Oct 29, 2020	BUY	$2.92 - $6.48 $1,673 - $3,713	573 Added 15.89%	4,178 $13,000
Q2 2020 Aug 05, 2020	BUY	$2.25 - $8.77 $8,111 - $31,615	3,605 New	3,605 $32,000

406K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $89.4M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.